Iosif Pediaditakis

Company: Alchemab Therapeutics

Job title: Associate Director, Neuroscience

Seminars:

Evaluating the Role of Biomarkers for Evaluating Treatment Response & Disease Progression in Neuroinflammatory Disorders 1:15 pm

Leveraging Organ-on-Chip technology for studying neuroinflammatory diseases Understanding how neuroimmune interactions disrupt the blood-brain barrier in several neurological disorders Deciphering how to restore the blood-brain barrier breakdown, evident in many neuroinflammatory conditionsRead more

day: Conference Day Two